Save information for later
Sign Up

Learn About Neuroendocrine Tumor

What is the definition of Neuroendocrine Tumor?
Neuroendocrine tumors are rare cancers that grow from neuroendocrine cells. Neuroendocrine cells receive signals from the nervous system to release hormones. There are several types of neuroendocrine tumors, although most occur in the lungs, pancreas, adrenal glands, small intestine, appendix, and rectum. Neuroendocrine tumors may also spread to the lymph nodes, liver, or bones.
What are the symptoms of Neuroendocrine Tumor?
Symptoms of a neuroendocrine tumor depend on the tumor’s location and whether it is producing excess hormones. Symptoms of neuroendocrine tumors may include pain, a lump under the skin, fatigue, persistent cough or hoarseness, unexplained weight loss, confusion, anxiety, dizziness, shakiness, elevated blood glucose, low blood glucose, an ulcer, skin flushing, skin rash, increased thirst, nausea and vomiting, diarrhea, and carcinoid syndrome. Carcinoid syndrome is a condition that occurs when a neuroendocrine tumor produces excess hormones. Symptoms of carcinoid syndrome include skin flushing of the head and neck; sweating; shortness of breath; wheezing; rapid heartbeat; heart murmur; high blood pressure; yellowing of the skin and eyes; abdominal cramping; diarrhea; greasy, foul-smelling bowel movements; and swelling of the feet and legs.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Neuroendocrine Tumor?
Treatment for neuroendocrine tumors depends on the type and location, as well as whether the tumor is producing excess hormones. Treatment for endocrine tumors may include surgery; chemotherapy; targeted drug therapy, such as everolimus and sunitinib; immunotherapy, such as interferon alfa-2b; peptide receptor radionuclide therapy; somatostatin analogs, such as octreotide and lanreotide; radiation therapy; radiofrequency ablation; and hepatic artery embolization.
Who are the top Neuroendocrine Tumor Local Doctors?
Distinguished in Neuroendocrine Tumor
Hematology Oncology | Hematology | Oncology
Distinguished in Neuroendocrine Tumor
Hematology Oncology | Hematology | Oncology

Rocky Mountain Cancer Centers Llp

2312 N Nevada Ave, Suite 400, 
Colorado Springs, CO 
 (9.0 mi)
Languages Spoken:
English
Offers Telehealth

Sofyan Radaideh is a Hematologist Oncology specialist and a Hematologist in Colorado Springs, Colorado. Dr. Radaideh and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Leukocytosis, Chronic Lymphocytic Leukemia (CLL), and Chronic B-Cell Leukemia (CBCL).

Distinguished in Neuroendocrine Tumor
Gastroenterology
Distinguished in Neuroendocrine Tumor
Gastroenterology

Peak Gastroenterology Associates

2920 N Cascade Ave, Suite 300, 
Colorado Springs, CO 
 (9.6 mi)
Languages Spoken:
English

Neil Sharma is a Gastroenterologist in Colorado Springs, Colorado. Dr. Sharma and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Choledocholithiasis, Barrett Esophagus, Pancreatic Cancer, Endoscopy, and Pancreatectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Neuroendocrine Tumor
Pediatrics | Internal Medicine
Advanced in Neuroendocrine Tumor
Pediatrics | Internal Medicine

Poudre Valley Medical Group LLC

1400 E Boulder St, 
Colorado Springs, CO 
 (7.1 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sabine Shaffer is a Pediatrics specialist and an Internal Medicine provider in Colorado Springs, Colorado. Dr. Shaffer and is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Melorheostosis, Osteopenia, and Melorheostosis with Osteopoikilosis. Dr. Shaffer is currently accepting new patients.

What are the latest Neuroendocrine Tumor Clinical Trials?
A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Summary: This protocol will enroll patients with pancreatic adenocarcinoma and adenosquamous carcinoma (Cohort 1), gastrointestinal/pancreatic neuroendocrine neoplasms with Ki-67 \> 20% (Cohort 2) and neuroendocrine prostate carcinoma (Cohort 3)). Each cohort will have its own interim analysis after enrollment of 10 patients. Subjects will be given a one-month (28 day) supply of study drug (ESK981). Subjec...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomised Study of Cessation of Somatostatin Analogues After Peptide Receptor Radionuclide Therapy in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (STOPNET)

Summary: Neuroendocrine tumours (NETs) are slow growing cancers, which commonly present as metastatic incurable disease. Some neuroendocrine tumours, termed functional NETs, overproduce hormones which result in a variety of symptoms. However, approximately 75% of NETs are considered non-functional meaning that they do not result in hormone overproduction. The main treatment for both functional and non-func...

What are the Latest Advances for Neuroendocrine Tumor?